| Literature DB >> 35797393 |
Gebre Kayta1, Aseer Manilal1, Dagimawie Tadesse1, Munira Siraj1.
Abstract
The levels of indoor air microbial load in hospitals are very crucial to the health of patients and health care workers and are to be regularly monitored and maintained at an acceptable level. However, this problem remains overlooked, particularly in developing countries including Ethiopia. A hospital-based cross-sectional study is designed to determine the indoor air microbial load (settle plate technique), microbial isolates (standard microbiological techniques), bacterial susceptibility profiles (Kirby-Bauer disk diffusion technique), and associated factors, in different wards of the title Hospital, southern Ethiopia. An observational checklist was used to collect relevant information related to the associated factors; descriptive and inferential statistics were applied using Statistical Package for Social Sciences (SPSS); p-values ≤ 0.05 in the multivariable analysis were considered statistically significant. The total average bacterial and fungal load of the selected wards was 1914±1081.4 Colony Forming Units (CFU)/m3 (95% CI: 1718.5-2109.48 CFU/m3) and 1533.7±858.8 CFU/m3 (95% CI: 1378.5-1688CFU/m3) respectively. The highest mean bacterial (1914±1081.4 CFU/m3) and fungal (1533.7±858.8 CFU/m3) loads were found in the male surgical and female medical wards respectively. A total of 229 bacterial and 139 fungal isolates were obtained; Gram-positive bacteria were the predominant type, 130 (56.7%), particularly the isolates of Staphylococcus aureus, 46 (20.1%). The predominant fungal isolates were Aspergillus sp., 53(38%). Percentages of multidrug-resistant (MDR), extended-spectrum beta-lactamase (ESBL), and carbapenemase producers respectively were 48.5, 26.5, and 25%. High room crowd index [p = 0.003; Adjusted Odds Ratio (AOR) 12.5 (Confidence Interval (CI) 95%: 2.42-65)], presence of damp/wet materials [p = 0.025; AOR 7 (CI 95%: 1.3-37.4)], intense room traffic [p = 0.004; AOR 9.6 (CI 95%: 1.2-79.3)], inappropriate storage of food and drugs [p = 0.008; AOR 7.5 (CI 95%: 1.7-32)], and unclean environment [p = 0.03; AOR 5.8 (CI 95%: 1.2-28)] showed statistical significance concerning the indoor air microbial loads; most of the wards in Arba Minch General Hospital (AMGH) stand high and not in an acceptable level as per the WHO and the European Commission standards on indoor air microbial load. Periodic air surveillance and infection prevention control programs are required to reduce the transmission of these microbes to inpatients, visitors, and health care workers.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35797393 PMCID: PMC9262214 DOI: 10.1371/journal.pone.0271022
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Average means of microbial load of different wards in the AMGH versus the WHO expert group and European commission sanitary standards for non-industrial premises.
| Wards | Bacteria (Mean CFU/m3 ± SD) n = 12 | 95% CI | Fungi (Mean CFU/m3 ± SD) n = 12 | 95% CI | WHO standard | European Standard |
|---|---|---|---|---|---|---|
| OR | 676.5±202.7 | 547.7–805.3 | 632±147 | 538.9–7725.7 | Acceptable | High |
| ORTHW | 887.08±498.75 | 570.2–1204 | 699±454.54 | 410.4–988 | Acceptable | High |
| MSW | 2957.5±669.76 | 2531.9–3383 | 1972±774 | 1480–2464 | Unacceptable | Very high |
| FSW | 2515±1152.8 | 1782.5–3247.4 | 1787.2±915 | 1205–2368 | Unacceptable | Very high |
| ICU | 1095.75±351.3 | 872.5–1319 | 1053.9±367 | 820–1287.3 | Unacceptable | High |
| PW | 2008.5±789.73 | 1506.7–2510.3 | 1770.5±800 | 1261–2279.3 | Unacceptable | Very high |
| FMW | 2495±832.69 | 1966.2–3024.3 | 2288±718.6 | 1831–2745.2 | Unacceptable | Very high |
| MMW | 2504.42±611.7 | 2115.7–2893.0 | 2042±761 | 1558–2525.6 | Unacceptable | Very high |
| E-WARD | 1071.6±751.5 | 594.2–1549.17 | 953.5±547. | 605–1301.5 | Unacceptable | High |
| GYNW | 2928.33±645.6 | 2518.08–3338 | 2137±484.6 | 1829–2444.9 | Unacceptable | Very high |
| Total (average) | 1914±1081.4 | 1718.52–2109 | 1533.7±858 | 1378.5–1688 | Unacceptable | High |
OR: Operation Room, ORTHW: Orthopedic Ward, MSW: Male surgical ward, FSW: Female surgical ward, ICU: Intensive Care Unit, PW: Pediatrics ward, FMW: Female Medical Ward, MMW: Male Medical Ward, GYNW: Gynecology ward, SD: standard deviation, n = 12 plates per room.
WHO expert group microbial load standard: Both bacterial and fungal load <1000 CFU/m3 as extrapolated as acceptable and either bacterial or fungal load ≥1000 CFU/m3 are considered as unacceptable. European Commission for non-industrial premises sanitary standard for microbial load less than 50 CFU/m3 as ‘very low’ bacterial load, 50–100 CFU/m3 as ‘low’, 100–500 CFU/m3 as ‘intermediate’, 500–2000 CFU/m3 as ‘ high’ and above 2000 CFU/m3 as ‘very high’.
Profiles of bacterial isolates identified from the indoor air of selected wards of AMGH, February-April 2021.
| Bacterial isolates | Selected wards of AMGH | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Frequency | Pediatrics Ward | Gynecology Ward | Orthopedic Ward | Male surgical Ward | Female surgical Ward | ICU | OR | FMW | MMW | E-ward | |
| n (%) | |||||||||||
| Gram-positive | 130(56.8) | 24(18.5) | 20(15.4) | 10(7.7) | 16(12.3) | 11(8.5) | 10(7.7) | 8(6.2) | 9(7) | 11(8.5) | 11(8.5) |
| 46(20) | 9(19.6) | 8(17.4) | 4(8.7) | 7(15) | 2(4.39) | 3(6.5) | 3(6.5) | 3(6.5) | 4(8.7) | 3(6.5) | |
| CoNS | 40(17.5) | 10(25) | 5(12.5) | 3(7.5) | 5(12.5) | 4(10) | 3(7.50) | 3(7.5) | 2(5) | 3(7.5) | 2(5) |
| 22(9.6) | 3(13.4) | 1(4.5) | 3(13.4) | 3(13.4) | 3(13.4) | 2(13.4) | 2(18) | 2(9) | 1(4.5) | 2(9) | |
| 11(4.8) | 1(9) | 2(18) | 0(0) | 1(9) | 2(18) | 1(9) | 0(0) | 1(9) | 2(18) | 1(9) | |
| 7(3.1) | 1(14.3) | 2(28.6) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 1(14.3) | 1(14.3) | 2(14.3) | |
| 4(1.7) | 0(0) | 2(650) | 0(0) | 0(0) | 0(0) | 1(25) | 0(0) | 0(0) | 0(0) | 1(25) | |
| Gram-negative | 99(43) | 21(21) | 12(12) | 7(7) | 15(15) | 11(11) | 5(5) | 3(3) | 12(12) | 8(8) | 5(5) |
| 21(9.2) | 4(19) | 2(9.5) | 2(9.5) | 4(19) | 2(9.5) | 1(4.8) | 1(4.8) | 3(14.3) | 1(4.8) | 1(4.8) | |
| 18(7.8) | 4(22.2) | 3(16.7) | 1(5.6) | 2(11) | 3(16.7) | 1(5.6) | 0(0) | 2(11) | 2(11) | 0(0) | |
| 16(7) | 3(18.7) | 2(12.5) | 1(6.3) | 3(18.7) | 2(12.5) | 1(6.3) | 1(6.3) | 2(12.5) | 1(6.3) | 0(0) | |
| 15(6.6) | 2(13.3) | 2(13.3) | 0(0) | 3(20) | 2(13.3) | 0(0) | 1(6.7) | 2(13.3) | 1(6.7) | 2(13.3) | |
| 11(4.8) | 3(27.3) | 1(9) | 1(9) | 0(0) | 0(0) | 2(18) | 0(0) | 2(18) | 1(9) | 1(9) | |
| 8(3.5) | 2(25) | 1(12.5) | 0(0) | 2(25) | 1(12.5) | 0(0) | 0(0) | 1(12.5) | 1(12.5) | 0(0) | |
| 6(2.6) | 1(16.7) | 1(16.7) | 1(16.7) | 1(16.7) | 1(16.7) | 0(0) | 0(0) | 0(0) | 0(0) | 1(16.7) | |
| 4(1.7) | 2(50) | 0(0) | 1(25) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 1(25) | 0(0) | |
|
|
| ||||||||||
ICU: Intensive Care Unit, OR: Operation Room, FMW: female medical ward, MMW: male medical ward, n: number of isolates
Profiles of fungal isolates identified from indoor air of selected wards of AMGH, February-April 2021.
| Fungal Isolates | Frequency (percent) | Pediatrics ward | Gynecology ward | Orthopedic ward | Male surgical Ward | Female surgical Ward | ICU | OR | FMW | MMW | E-ward |
|---|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | |||||||||||
| 53(3.1) | 8(15) | 7(13) | 2(3.8) | 8(15) | 7(13) | 5(9.4) | 2(3.8) | 6(11.3) | 5(9.4) | 3(5.7) | |
| 42(30.2) | 5(12) | 9(12.4) | 1(2.4) | 6(14.3) | 4(9.5) | 3(7.1) | 1(2.4) | 5(12) | 6(14.3) | 2(4.8) | |
| 28(20.1) | 4(14.3) | 2(7.1) | 2(7.1) | 6(21) | 3(10.7) | 0(0) | 0(0) | 6(21) | 4(14.4) | 1(3.6) | |
| 17(12.2) | 4(23.5) | 5(29.4) | 0(0) | 1(5.9) | 4(5.9) | 0(0) | 0(0) | 2(11.8) | 1(11.8) | 0(0) | |
| 16(11.5) | 5(31.3) | 3(18.8) | 0(0) | 3(31.3) | 1(6.3) | 0(0) | 0(0) | 1(6.3) | 0(0) | 0(0) | |
| 13(9.4) | 1(7.7) | 3(23) | 1(7.7) | 4(30.8) | 0(0) | 0(0) | 1(7.7) | 2(15.4) | 0(0) | 0(0) | |
| Total | 139(100) | 27(19.4) | 29(20.8) | 6(4.3) | 28(20) | 19(13.7) | 8(5.8) | 4(2.9) | 22(15.8) | 16(11.5) | 6(4.3) |
ICU: Intensive Care Unit, OR: Operation Room, FMW: female medical ward, MMW: male medical ward
Antibiotic susceptibility profiles of Gram-positive bacteria isolated from indoor air of selected wards of AMGH, February-April 2021.
| Bacterial Isolate | Susceptibility Pattern n (%) | Antimicrobial agents | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTR | CFP | GEN | TTC | CHL | CIP | MER | PEN | CXT | DOX | VAN | ERY | SXT | CLN | ||
| S | - | - | 26(57) | 31(67) | 43(93) | 31(67) | - | 21(46) | 26(57) | 39 (85) | - | 23 (50) | 30(65) | 34 (74) | |
| R | - | - | 20(43) | 15(33) | 3(7) | 15(33) | - | 25(54) | 20(43) | 7(15) | - | 23 (50) | 16(35) | 12 (26) | |
| CoNS n = 40 | S | - | - | 23(58) | 12(30) | 35(88) | 30(75) | - | 24(60) | 32(80) | 22 (55) | - | 17 (42) | 11(27) | 27 (67) |
| R | - | - | 17(42) | 28(70) | 5(12) | 10(25) | - | 16(40) | 8(20) | 18 (45) | - | 23(58) | 29(73) | 13 (33) | |
| S | - | - | - | 2(9) | 16(73) | 4(18) | - | 0(0) | - | 2(9) | 4 (18) | 4(18) | - | - | |
| R | - | - | - | 20(91) | 6(27) | 18(82) | - | 22(100%) | - | 20(91) | 18(82) | 18(82) | - | - | |
| S | 3(27) | 10(91) | - | 6(55) | 9(82) | - | 11(100) | - | - | - | - | 8(73) | - | 7 (64) | |
| R | 8(73) | 1(9) | - | 5(45) | 2(18) | - | 0(0) | - | - | - | - | 3(27) | - | 4 (37) | |
| S | 2(29) | 1(14) | 0(0) | 3(43) | 4(57) | 0(0) | 2(29) | 0(0) | - | 3(43) | - | - | - | - | |
| R | 5(71) | 6(86) | 7(100) | 4(57) | 3(43) | 7(100) | 5(71) | 7(100) | - | 4 (57) | - | - | - | - | |
| S | 1(25) | 0(0) | 2(50) | 1(25) | 1(25) | 0(0) | 0(0) | - | 2 (50) | 0 (0) | - | - | - | - | |
| R | 3(75) | 4(100) | 2(50) | 3(75) | 3(75) | 4(100) | 4(100) | - | 2 (50) | 4 (100) | - | - | - | - | |
| Total tested | 22 | 22 | 97 | 130 | 130 | 119 | 22 | 115 | 90 | 119 | 22 | 119 | 86 | 97 | |
| Average S | S | 6(27) | 11(50) | 51(53) | 55(42) | 108(83) | 65(55) | 13(59) | 45(39) | 60(67) | 66 (56) | 4(18) | 52(44) | 42 (48) | 68 (70) |
| Average R | R | 16(73) | 11(50) | 46(47) | 75(58) | 22(17) | 54(45) | 9(41) | 70(61) | 30(33) | 53 (44) | 18(82) | 67(56) | 45 (52) | 29 (30) |
CTR: ceftriaxone, CFP: cefopime, GEN: gentamicin, TTC: tetracycline, CHL: chloramphenicol, CIP: ciprofloxacin, MER: meropenem, CXT: cefoxitin, DOX: doxycycline, VAN: vancomycin, ERY: erythromycin, SXT: sulfamethoxazole-trimethoprim, CLN: clindamycin.
Antibiotic susceptibility profiles of Gram-negative bacteria isolated from indoor air of selected wards of AMGH, February-April 2021.
| Bacterial Isolate | Susceptibility Pattern n(%) | Antimicrobial agents | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | PIP | CTR | CFP | AGU | GEN | CHL | CIP | MER | TTC | SXT | ||
| S | 9(60) | 13(87) | 8(53) | 5(33) | 5(33) | 9(60) | 13(87) | 8(53) | 6(40) | 3(20) | 4(40) | |
| R | 6(40) | 2(13) | 7(47) | 10(67) | 10(67) | 6(40) | 2(13) | 7(47) | 9(60) | 12(80) | 9(60) | |
| S | - | 18(86) | 13(62) | 13(62) | 7(33) | 7(34) | 8(38) | 3(14) | 8(38) | 4(19) | 6(29) | |
| R | - | 3(14) | 8(38) | 8(38) | 14(67) | 14(66) | 13(62) | 18(86) | 13(62) | 17(81) | 15(71) | |
| S | - | 7(64) | 7(64) | 5(45) | - | 6(55) | 9(82) | 7(63) | 4(37) | 2(18) | 3(28) | |
| R | - | 4(36) | 4(36) | 6(55) | - | 5(45) | 2(18) | 4(37) | 7(63) | 9(82) | 8(72) | |
| S | - | 5(62) | 7(88) | 6(75) | - | 4(50) | 7(88) | 3(38) | 4(50) | 5(62) | 1(13) | |
| R | - | 3(38) | 1(12) | 2(25) | - | 4(50) | 1(12) | 5(62) | 4(50) | 3(38) | 7(87) | |
| S | - | 2(50) | 3(75) | 2(50) | 2(50) | 0(0) | 1(25) | 2(50) | 2(50) | - | 0(0) | |
| R | - | 2(50) | 1(25) | 2(50) | 2(50) | 4(100) | 3(75) | 2(50) | 2(50) | - | 4(100) | |
| S | 4(67) | 5(83) | 3(50) | 4(67) | 1(17) | 3(50) | 2(33) | 3(50) | 2(33) | 1(17) | 2(33) | |
| R | 2(33) | 1(17) | 3(50) | 2(33) | 5(83) | 3(50) | 4(67) | 3(50) | 4(67) | 5(83) | 4(67) | |
| S | - | 5(28) | - | 6(33) | - | 6(33) | - | 7(39) | 5(28) | - | - | |
| R | - | 13(72) | - | 12(67) | - | 12(67) | - | 11(61) | 13(72) | - | - | |
| S | - | 10(62) | 5(31) | 8(50) | - | 8(50) | - | 5(31) | 6(38) | 9(56) | 4(25) | |
| R | - | 6(38) | 11(69) | 8(50) | - | 8(50) | - | 11(69) | 10(62) | 7(44) | 12(75) | |
| Total tested isolates | 22 | 99 | 81 | 99 | 46 | 99 | 65 | 99 | 99 | 77 | 81 | |
| Average susceptibility | 13(59) | 65(65) | 46(57) | 49(50) | 15(33) | 43(43) | 40(62) | 38(38) | 37(37) | 24(31) | 20(25 | |
| Average resistant | 9(41) | 34(35) | 35(43) | 50(50) | 31(67) | 56(56) | 25(38) | 62(62) | 63(63) | 53(69) | 61(75) | |
AMP: ampicillin, PIP: piperacillin, CFP: cefopime, CTR: ceftriaxone, GEN: gentamicin, CIP: ciprofloxacin, MER: meropenem, CHL: chloramphenicol, TTC: tetracycline, SXT: sulfamethoxazole-trimethoprim, AGU: amoxicillin-clavulanate, R: resistant, S: susceptible
MDR, ESBLs and carbapenemase enzyme production patterns of Gram-negative isolates.
| Bacterial isolates | MDR n (%) | ESBLs producers n (%) | Carbapenemase producers n (%) | ESBLs and carbapenemase producers n (%) |
|---|---|---|---|---|
| 7(46.6) | 5(33.3) | 3(20) | 2(13.3) | |
| 12(57) | 6(28.5) | 5(23.8) | 3(14.3) | |
| 6(54.5) | 2(18.2) | 1(9) | 0(0) | |
| 4(66.7) | 2(33.3) | 1(16.7) | 0(0) | |
| 8(44.4) | 3(16.7) | 13(72.2) | 1(5.5) | |
| 12(75) | 7(43.8) | 2(12.5) | 0(0) | |
| 4(50) | 1(12.5) | 0(0) | 0(0) | |
| 1(25) | 0(0) | 0(0) | 0(0) | |
| Gram-negative Total (n = 99) | 54(54) | 26(26.3) | 25(25) | 6(6) |
| 26(56.5) | ND | ND | ND | |
| CoNS (n = 40) | 21(52.5) | ND | ND | ND |
| 8(36.4) | ND | ND | ND | |
| 2(18.2) | ND | ND | ND | |
| 7(100) | ND | ND | ND | |
| 4(100) | ND | ND | ND | |
| Gram-positive Total(n = 130) | 68(52.3) | ND | ND | ND |
| Average total (n = 229) |
| ND | ND | ND |
MDR: multiple drug resistant, ESBL: extended spectrum beta-lactamase, n: isolates, ND = not done
Logistic regression model analysis of independent variables associated to the indoor air microbial load.
| Characteristics | WHO expert group standard | Bivariable analysis | Multivariable analysis | |||
|---|---|---|---|---|---|---|
| <1000 CFU/m3 | ≥1000 CFU/m3 | P-value | COR (95%CI) | P-value | AOR (95%CI) | |
|
| N (%) | |||||
| >2(high) | 8(6.7%) | 55(45.8%) | 0.00 | 25.8(8.8–75.6) | 0.003 | 12.5(2.42–65) |
| 1-2(medium) | 10(8.3%) | 9(7.5%) | 0.045 | 3.4 (1.02–11.1) | 0.425 | 2.14(0.33–13.8) |
| <1(low) | 30(25%) | 8(6.7%) | 1 | 1 | ||
|
| 1 | |||||
| Yes | 20(16.7%) | 35(29.2%) | 1 | |||
| No | 28(20.8%) | 37(30.8%) | 0.455 | 0.755 (0.36–1.58) | - | - |
|
| ||||||
| Below 250c | 21(17.5%) | 25(20.8%) | 1 | |||
| 25-280c | 12(10%) | 4(3.3%) | 0.086 | 2.551 (0.87–7.4) | 0.37 | 2.75(0.29–25.5) |
| Above 280c | 11(9.2%) | 38(31.7%) | 0.00 | 7.143(2.36–21.57) | 0.52 | 1.6(0.38–6.8) |
|
| ||||||
| Yes | 5(4.2%) | 30(25%) | 0.001 | 6.14(2.18–17.34) | 0.025 | 7(1.3–37.4) |
| No | 43(35.8%) | 42(35%) | 1 | 1 | ||
|
| ||||||
| Yes | 16(13.3) | 22(18.3%) | 0.74 | 0.88(0.403–1.92) | - | - |
| No | 32(26.7%) | 50(41.7%) | 1 | 1 | ||
|
| ||||||
|
| 10(8.3%) | 26(21.2%) | 0.07 | 2.148 (0.921–5.0) | 0.35 | 0.5(0.121–2.1) |
|
| 38(31.7%) | 46(38.3%) | 1 | 1 | ||
|
| ||||||
| high | 16(13.3%) | 60(50%) | 0.001 | 14.06 (4.1–48) | 0.036 | 9.6(1.2–79.3) |
| medium | 17(14.2%) | 8(6.7%) | 0.42 | 1.76(0.441–7.06) | 0.418 | 2.6(0.25–27) |
| low | 15(12.5%) | 4(3.3%) | 1 | 1 | ||
|
| ||||||
| Yes | 29(24.2%) | 33(27.5%) | 1 | |||
| No | 19(15.8%) | 39(32.5%) | 0.119 | 1.8 (0.86–3.8) | 0.54 | 1.5(0.4–5.7) |
|
| ||||||
| Yes | 26(21.2) | 35(29.2%) | 1 | 1 | ||
| No | 22(18.3%) | 37(30.8%) | 0.551 | 1.25 (0.601–2.598) | - | - |
|
| ||||||
| Yes | 26(21.7%) | 23(19.2%) | 1 | 1 | ||
| No | 22(18.3%) | 49(40.8%) | 0.016 | 2.52 (1.185–5.34) | 0.56 | 1.4(0.43–4.7) |
|
| ||||||
| Yes | 22(18.3%) | 59(49.2%) | 1 | 1 | ||
| No | 23(19.2%) | 22(18.3%) | 0.001 | 5.37(2.3–12.26) | 0.008 | 7.5(1.7–32) |
|
| ||||||
| Yes | 22(18.3%) | 22(18.3%) | 1 | 1 | ||
| No | 25(20.8%) | 50(41.2%) | 0.056 | 2.1(0.98–4.455) | 0.43 | 0.58(0.15–2.23) |
|
| ||||||
| Yes | 31(25.8%) | 7(5.8) | 1 | 1 | ||
| No | 17(14.2%) | 65(54.2%) | 0.001 | 17(6.3–45.1) | 0.03 | 5.8(1.2–28) |
Note:
*Statistically significant at P<0.25
** statistically significant at P<0.05, AOR: Adjusted odds ratio, COR: Crude odds ratio, 1: reference group, CI: Confidence interval